What We're Reading: Page 118
Industry reads hand-picked by our editors
May 03, 2022
May 02, 2022
Apr 29, 2022
-
The Wall Street Journal
Biotech Venture Capital Investment in China Climbs
-
BioCentury
Woodcock to remain at FDA, with focus on operations
-
The Financial Times
Moderna investors reject proposal to transfer vaccine tech
-
Politico
Califf: FDA to move 'as fast as we can' on Moderna vaccine request for kids
Apr 28, 2022
-
Science
India’s speedy approvals of COVID-19 vaccines come under fire
-
Scientific American
How to Tell whether a Cancer Is Caused by Plain Bad Luck
-
Endpoints News
Can this tick biologist and her team of ‘weirdo science’ enthusiasts change the future of scientific research?
-
Reuters
Betting big on drug discovery, UK's OMass Therapeutics raises $100 mln
Apr 27, 2022
-
BioCentury
How Hatch shaped FDA law by finding common ground
-
The Financial Times
GSK beats forecasts on back of Covid and shingles treatments
-
The Wall Street Journal
Johnson & Johnson Files Suit Against Alleged HIV-Drug Counterfeiters
Apr 26, 2022
-
Science
NYU may hire biologist pushed out of MIT, Whitehead for sexual misconduct
-
Bloomberg
Why Nasal Sprays Are Poised to Be the Next Weapon for Fighting Covid
-
Endpoints News
Protagonist reports a PhII fail in ulcerative colitis, but execs are pushing forward anyway
-
Fierce Biotech
Pfizer's $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies
Previous
